MSB 3.33% $1.40 mesoblast limited

Mesoblast owns the patents . The science is now proven .

  1. 442 Posts.
    lightbulb Created with Sketch. 12313
    Just out ... Read !!! “China is also pushing forward the utilization of some advanced technologies such as stem cell and artificial liver and blood purification in the treatment of severe cases.Zhang said stem cell therapy proves effective in reducing severe inflammatory reactions caused by Covid-19, as well as reducing lung injury and pulmonary fibrosis in patients.China has initiated several clinical research programs on stem cell therapy against Covid-19, including a stem cell drug that has been approved for clinical trial and a mesenchymal stem cell therapy.Stem cell therapy has been used to treat 64 patients in severe and critical condition. Those patients' breathing difficulties were gradually relieved and they were generally cured in eight to 10 days.The therapy also showed advantages in preventing pulmonary fibrosis and improving the long-term prognosis for patients.The Chinese Society for Cell Biology and the Chinese Medical Association have jointly issued a guideline to standardize the clinical research and application of stem cell therapy against Covid-19”

    The results are staring you in the face. Yes, these will have to be duplicated in due course around the world ....but Mesoblast owns the patents . Fact .

    Prof Itescu and his team are amazing .
    Remember the treatment for ARDS is also relevant to severe influenza , sepsis, COPD and many other conditions .

    In my opinion Mesoblast is THE world leader in regenerative medicine. The read outs for heart disease and chronic lower back pain are around the corner . What an opportunity even in a market meltdown. What price would a government pay right now for this technology ?
    https://www.thestar.com.my/news/regional/2020/03/17/china-reports-new-progress-in-drug-therapies-against-covid-19
    Please do your own research and do not rely on the opinion or facts in the above post when making an investment decision .
    Last edited by otherperspective: 19/03/20
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.40
Change
0.045(3.33%)
Mkt cap ! $1.592B
Open High Low Value Volume
$1.35 $1.42 $1.33 $3.802M 2.753M

Buyers (Bids)

No. Vol. Price($)
2 23940 $1.39
 

Sellers (Offers)

Price($) Vol. No.
$1.40 22571 2
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.